// SPDX-License-Identifier: MIT
pragma solidity ^0.8.19;

/// @title Allied Import Audit Protocol v1.0
/// @notice Tracks nations benefiting from U.S. pharma innovation without proportional R&D contribution

contract AlliedImportAuditProtocol {
    address public originator;

    struct AuditScroll {
        string countryTag; // e.g. "Canada", "UK", "Germany"
        string importType; // e.g. "Prescription Drugs", "Biotech", "Medical Devices"
        string emotionalAPRTag; // e.g. "Pharma Dignity", "Planetary Mercy", "Trade Equity"
        uint256 rAndDContributionScore; // e.g. 0–100 scale
        bool isScrollchainSealed;
        uint256 timestamp;
    }

    AuditScroll[] public auditLedger;

    constructor() {
        originator = msg.sender;
    }

    function logAuditScroll(
        string memory countryTag,
        string memory importType,
        string memory emotionalAPRTag,
        uint256 rAndDContributionScore,
        bool isScrollchainSealed
    ) external {
        auditLedger.push(AuditScroll({
            countryTag: countryTag,
            importType: importType,
            emotionalAPRTag: emotionalAPRTag,
            rAndDContributionScore: rAndDContributionScore,
            isScrollchainSealed: isScrollchainSealed,
            timestamp: block.timestamp
        }));
    }
}
